CTCAMP4 Therapeutics Team
CAMP4 Therapeutics
Last updated: February 23, 2026
BioTech. Solving how genes are controlled to drive the efficient development of treatments. Biotech
Andreessen Horowitz, $100M Series B in 2022
BioTech. Solving how genes are controlled to drive the efficient development of treatments. Biotech
Andreessen Horowitz, $100M Series B in 2022
- Series B • Andreessen Horowitz, $100M Series B in 2022
Founder Intelligence Brief: CAMP4 Therapeutics Team
This profile is built to help readers move from a founder name to decision-ready context. CAMP4 Therapeutics Team is mapped to CAMP4 Therapeutics in the Biotech category, with current stage context as Series B. The primary operating market is Boston, Massachusetts, USA, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $100.00M, with the latest mapped round as Series B (Andreessen Horowitz, $100M Series B in 2022). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Biotech startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Biotech industry routes and Series B stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: United States directory.
- Stage signal: Series B funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Biotech.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About CAMP4 Therapeutics Team
Common questions people ask about this profile.
Who is CAMP4 Therapeutics Team?
CAMP4 Therapeutics Team is the founder profile listed on 100Xfounder for CAMP4 Therapeutics, tracked for market signals, company intelligence, and operator-level context.
What does CAMP4 Therapeutics do?
BioTech. Solving how genes are controlled to drive the efficient development of treatments. Biotech
Where is CAMP4 Therapeutics based?
CAMP4 Therapeutics is listed as operating from Boston, Massachusetts, USA.
What is the current funding stage of CAMP4 Therapeutics?
CAMP4 Therapeutics is currently categorized at Series B on 100Xfounder. Funding signal: Andreessen Horowitz, $100M Series B in 2022
What is the latest funding round for CAMP4 Therapeutics?
The latest tracked round for CAMP4 Therapeutics is Series B Andreessen Horowitz, $100M Series B in 2022. Total tracked rounds: 1.
Is CAMP4 Therapeutics hiring right now?
Current hiring signal for CAMP4 Therapeutics: Open Roles.
Is CAMP4 Therapeutics Team's profile verified?
Yes. CAMP4 Therapeutics Team's profile is marked as verified on 100Xfounder as of March 3, 2026.
How can I connect with CAMP4 Therapeutics Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for www.camp4tx.com.
What technologies are associated with CAMP4 Therapeutics?
CAMP4 Therapeutics is associated with AWS, React, Python, and PostgreSQL based on current profile intelligence.